NIEMEYER, P., M. HANUS, J. BELICKAS, T. LÁSZLÓ, R. GUDAS, M. FIODOROVAS, A. CEBATORIUS, M. PASTUCHA, P. HOZA, K. MAGOS, K. IZADPANAH, Libor PAŠA, G. VÁSÁRHELYI, K. SISÁK, M. MOHYLA, C. FARKAS, O. KESSLER, S. KYBAL, R. SPIRO, A. KÖHLER, A. KIRNER, S. TRATTNIG a C. GAISSMAIER. Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: Two-Year Results of a Prospective, Multicenter, Single-Arm Phase III Trial. Cartilage. THOUSAND OAKS: Sage, 2022, roč. 13, č. 1, s. 1-14. ISSN 1947-6035. Dostupné z: https://dx.doi.org/10.1177/19476035221085146.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: Two-Year Results of a Prospective, Multicenter, Single-Arm Phase III Trial
Autoři NIEMEYER, P., M. HANUS (203 Česká republika), J. BELICKAS, T. LÁSZLÓ, R. GUDAS, M. FIODOROVAS, A. CEBATORIUS, M. PASTUCHA (203 Česká republika), P. HOZA (203 Česká republika), K. MAGOS, K. IZADPANAH, Libor PAŠA (203 Česká republika, domácí), G. VÁSÁRHELYI, K. SISÁK, M. MOHYLA (203 Česká republika), C. FARKAS, O. KESSLER, S. KYBAL, R. SPIRO, A. KÖHLER, A. KIRNER, S. TRATTNIG a C. GAISSMAIER.
Vydání Cartilage, THOUSAND OAKS, Sage, 2022, 1947-6035.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30211 Orthopaedics
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.800
Kód RIV RIV/00216224:14110/22:00125638
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1177/19476035221085146
UT WoS 000777647800001
Klíčová slova anglicky autologous chondrocyte implantation; cartilage repair; hydrogel; knee; large defects
Štítky 14110711, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 19. 7. 2022 13:22.
Anotace
Objective: To evaluate the clinical outcome of a hydrogel-based autologous chondrocyte implantation (ACI) for large articular cartilage defects in the knee joint. Design: Prospective, multicenter, single-arm, phase III clinical trial. ACI was performed in 100 patients with focal full-thickness cartilage defects ranging from 4 to 12 cm2 in size. The primary outcome measure was the responder rate at 2 years using the Knee Injury and Osteoarthritis Outcome Score (KOOS). Results: Two years after ACI treatment, 93% of patients were KOOS responders having improved by ≥10 points compared with their pre-operative level. The primary endpoint of the study was met and demonstrated that the KOOS response rate is markedly greater than 40% with a lower 95% CI (confidence interval) of 86.1, more than twice the pre-specified no-effect level. KOOS improvement (least squares mean) was 42.0 ± 1.8 points (95% CI between 38.4 and 45.7). Mean changes from baseline were significant in the overall KOOS and in all 5 KOOS subscores from Month 3 (first measurement) to Month 24 (inclusive) (P < 0.0001). The mean MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) score after 24 months reached 80.0 points (95% CI: 70.0-90.0 points) and 92.1 points in lesions ≤ 5 cm2. Conclusions: Overall, hydrogel-based ACI proved to be a valuable treatment option for patients with large cartilage defects in the knee as demonstrated by early, statistically significant, and clinically meaningful improvement up to 2 years follow-up. Parallel to the clinical improvements, MRI analyses suggested increasing maturation, re-organization, and integration of the repair tissue.
VytisknoutZobrazeno: 15. 7. 2024 20:06